Licensed Practical Nurse in Port Byron, NY Accepting Medicare

7 Licensed Practical Nurse nurses found. Showing 1 - 7

Amanda Lee Jennings, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 130 Main St, Box 142, Port Byron, NY 13140 Phone: 315-702-4975

Chrystal Behm, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Main St, Port Byron, NY 13140 Phone: 315-776-9700    Fax: 315-776-9701

Margaret Jenner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Main St, Port Byron, NY 13140 Phone: 315-776-9700

Tammy Lynn Brown, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8415 King Street Rd, Port Byron, NY 13140 Phone: 425-309-2558

Mrs. Kaintigern Adian Meaker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 Duck Lake Rd, Port Byron, NY 13140 Phone: 717-765-1184

Amy Tillmon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 20 Mcclellan St, Port Byron, NY 13140 Phone: 315-209-3771

Mrs. Christi Grace Littlefield, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 213 Main St, Port Byron, NY 13140 Phone: 315-776-4938

News Archive

Study: Majority of overweight or obese patients happy with abdominoplasty

Tummy tuck surgery (abdominoplasty) yields high patient satisfaction and improved quality of life in patients who are overweight or obese – despite a substantial risk of complications, reports a study in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Researchers identify mechanisms involved in acid pump

Researchers at Aarhus University, Denmark, have succeeded in identifying the mechanisms involved in what is known as the acid pump, which at the cellular level pumps acid into the stomach - in some cases leading to gastric ulcers and gastroesophageal reflux disease.

Monoclonal antibody nivolumab improves survival rates of melanoma patients

The monoclonal antibody nivolumab has shown promise as a therapeutic agent, particularly by improving the survival rates of melanoma patients. Jeffrey S. Weber, M.D., Ph.D., director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt Cancer Center will be presenting data from a retrospective analysis of the safety of nivolumab in 4 ongoing phase I-III studies in melanoma patients at the 2015 American Society of Clinical Oncology Annual Meeting in Chicago.

Nanoviricides herpes study discussed on CBS News report

NanoViricides, Inc. (OTC BB: NNVC.OB), reported today that the CBS affiliate TV station WBRZ interviewed Professor K. Gus Kousoulas , PhD, in which he explained the potential implications of the Company's nanoviricides™ anti-Herpes drug candidates.

Study provides better understanding of how dangerous cancer metastases arise

In order to colonize other organs and grow into metastases, tumor cells that detach from the parent tumor need to manipulate their new microenvironment and create a 'metastatic niche'.

Read more Medical News

› Verified 6 days ago